Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen

Cellular Physiology and Biochemistry

Volumn 33, Issue 2, 2014, Pages 365-374

  Liu, Hong ^a,b   Lu, Su ^a,b,c   Gu, Lin ^a,b   Gao, Yongchang ^a,b   Wang, Tong ^a,b   Zhao, Jing ^a,b   Rao, Jianyu ^c   Chen, Jun ^a   Hao, Xishan ^a,b   Tang, Shou Ching ^a,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Apoptosis; BAG 1; Breast cancer; Hormonal therapy; TAM resistance

Indexed keywords

AFIMOXIFENE; BAG 1 PROTEIN; SMALL INTERFERING RNA; ESTROGEN RECEPTOR; PROTEIN P33; PROTEIN P46; PROTEIN P50; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL STRAIN MCF 7; CELL VIABILITY; DOWN REGULATION; DRUG SENSITIVITY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENETIC TRANSFECTION; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; CANCER CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSCRIPTION FACTORS;

EID: 84895604555     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356676     Document Type: Article

References (36)

1. Jordan VC: Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 1993;110:507-517.
2. Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS: Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 2006;66:7334-7340.
3. Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH: Pathways to tamoxifen resistance. Cancer Lett 2007;256:1-24.
4. Badia E, Oliva J, Balaguer P, Cavailles V: Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. Curr Med Chem 2007;14:3035-3045.
5. Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G: BAG-1: A multifunctional regulator of cell growth and survival. Biochim Biophys Acta 2003;1603:83-98.
6. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC: Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with In vitro and In vivo chemoresponses. Blood 1998;91:3379-3389.
7. Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A, Tang SC: Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene 1998;17:981-989.
8. Tang SC, Shehata N, Chernenko G, Khalifa M, Wang X: Expression of BAG-1 in invasive breast carcinomas. J Clin Oncol 1999;17:1710-1719.
9. Yang X, Hao Y, Ding Z, Pater A, Tang SC: Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin Cancer Res 1999;5:1816-1822.
10. Shindoh M, Adachi M, Higashino F, Yasuda M, Hida K, Nishioka T, Ono M, Takayama S, Reed JC, Imai K, Totsuka Y, Kohgo T: BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma. Oral Oncol 2000;36:444-449.
11. Rorke S, Murphy S, Khalifa M, Chernenko G, Tang SC: Prognostic significance of BAG-1 expression in nonsmall cell lung cancer. Int J Cancer 2001;95:317-322.
12. Maki HE, Saramaki OR, Shatkina L, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Cato AC, Visakorpi T: Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer. J Pathol 2007;212:395-401.
13. Tang SC, Beck J, Murphy S, Chernenko G, Robb D, Watson P, Khalifa M: BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma. Breast Cancer Res Treat 2004;84:203-213.
14. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E, Reed JC: Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 1998;47:129-140.
15. Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR, Packham G: High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer 1999;81:1042-1051.
16. Yang X, Hao Y, Ferenczy A, Tang SC, Pater A: Overexpression of anti-Apoptotic gene BAG-1 in human cervical cancer. Exp Cell Res 1999;247:200-207.
17. Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, Rebbeck TR, Haffty BG, Reed JC: BAG-1: A novel biomarker predicting long-Term survival in early-stage breast cancer. J Clin Oncol 2001;19:992-1000.
18. Townsend PA, Dublin E, Hart IR, Kao RH, Hanby AM, Cutress RI, Poulsom R, Ryder K, Barnes DM, Packham G: BAG-i expression in human breast cancer: Interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. J Pathol 2002;197:51-59.
19. Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G: BAG-1 prevents stress-induced long-Term growth inhibition in breast cancer cells via a chaperone-dependent pathway. Cancer Res 2003;63:4150-4157.
20. Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, Brimmell M, Mullee MA, Johnson PW, Royle GT, Bateman AC, Packham G: The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene 2003;22:4973-4982.
21. Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI: Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology 2003;144:1032-1044.
22. Tichopad A, Dilger M, Schwarz G, Pfaffl MW: Standardized determination of real-Time PCR efficiency from a single reaction set-up. Nucleic Acids Res 2003;31:e122.
23. Chen J, Xiong J, Liu H, Chernenko G, Tang SC: Distinct BAG-1 isoforms have different anti-Apoptotic functions in BAG-1-Transfected C33A human cervical carcinoma cell line. Oncogene 2002;21:7050-7059.
24. Liu HY, Wang ZM, Bai Y, Wang M, Li Y, Wei S, Zhou QH, Chen J: Different BAG-1 isoforms have distinct functions in modulating chemotherapeutic-induced apoptosis in breast cancer cells. Acta Pharmacol Sin 200;30:235-241.
25. Ding Z, Yang X, Pater A, Tang SC: Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells. Biochem Biophys Res Commun 2000;270:415-420.
26. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-Treated, node-negative breast cancer. N Engl J Med 2004;351:2817-2826.
27. Millar EK, Anderson LR, McNeil CM, O'Toole SA, Pinese M, Crea P, Morey AL, Biankin AV, Henshall SM, Musgrove EA, Sutherland RL, Butt AJ: BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. Br J Cancer 2009;100:123-133.
28. Hohfeld J, Jentsch S: GrpE-like regulation of the hsc70 chaperone by the anti-Apoptotic protein BAG-1. EMBO J 1997;16:6209-6216.
29. Takayama S, Reed JC: Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 2001;3:E237-241.
30. Liu H, Liang Y, Li Y, Wang J, Wu H, Wang Y, Tang SC, Chen J, Zhou Q: Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis. Cancer Biol Ther2010;9:832-840.
31. Tang S-C, Huang Q, Chen J: Differential anti-Apoptotic functions of BAG-1 isoforms in breast cancer cells in the presence of estrogen and anti-estrogen. Breast Can Res Treat 2004(abstract);88:73.
32. Tang SC: BAG-1, an anti-Apoptotic tumour marker. IUBMB Life 2002;53:99-105.
33. Froesch BA, Takayama S, Reed JC: BAG-1L protein enhances androgen receptor function. J Biol Chem 1998;273:11660-11666.
34. Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC: RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 1998;273:14620-14625.
35. Takahashi N, Sasaki R, Takahashi J, Takayama S, Reed JC, Andoh T: BAG-1M, an isoform of Bcl-2-interacting protein BAG-1, enhances gene expression driven by CMV promoter. Biochem Biophys Res Commun 2001;286:807-814.
36. Afentakis M, Dowsett M, Sestak I, Salter J, Howell T, Buzdar A, Forbes J, Cuzick J: Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: A TransATAC study. Breast Cancer Res Treat 2013;140:253-262.